Binance Labs Invests in BIO Protocol to Accelerate Decentralized Science (DeSci) Funding

Main Takeaways:

Binance Labs has invested in BIO Protocol, a pioneering protocol transforming the way early-stage scientific research is financed and commercialized using blockchain technology.

At Binance Labs, we are dedicated to unlocking groundbreaking advancements that drive long-term, real-world impact by supporting projects building meaningful technology—an approach that closely aligns with our investment in BIO Protocol.

ZUG, Switzerland, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Binance Labs has invested in BIO Protocol (BIO), a pioneering protocol transforming the way early-stage scientific research is financed and commercialized using blockchain technology. This investment marks Binance Labs' first venture into the Decentralized Science (DeSci) sector.

BIO can be thought of as a Y Combinator for on-chain Science. The platform enables a global community of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.

Currently, BIO's network consists of seven BioDAOs focused on diverse areas such as cryopreservation, women's health, and psychedelics for mental health. The protocol's next cohort includes projects accelerating a cure for Long COVID and rare diseases, and developing ...